PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25376633-3	2015	Herein, AuNPs@POMD-pep (AuNPs: gold nanoparticles, POMD: polyoxometalate with Wells-Dawson structure, pep: peptide) were designed as a novel multifunctional Abeta inhibitor.	polyoxometalate I	57-72	amyloid beta precursor protein	Homo sapiens	157-162	
24595206-2	2014	Recently, our group found that polyoxometalate (POM) with a Wells-Dawson structure can efficiently inhibit Abeta aggregation.	polyoxometalate I	31-46	amyloid beta precursor protein	Homo sapiens	107-112	
24595206-2	2014	Recently, our group found that polyoxometalate (POM) with a Wells-Dawson structure can efficiently inhibit Abeta aggregation.	polyoxometalate I	48-51	amyloid beta precursor protein	Homo sapiens	107-112	
21433228-0	2011	Polyoxometalates as inhibitors of the aggregation of amyloid beta peptides associated with Alzheimer"s disease.	polyoxometalate I	0-16	amyloid beta precursor protein	Homo sapiens	53-65	
35137505-3	2022	Polyoxometalates (POMs), a kind of inhibitors to beta-amyloid peptide (Abeta) aggregation, are used as an example to exhibit the chemical PTM methods.	polyoxometalate I	0-16	amyloid beta precursor protein	Homo sapiens	49-69	
35137505-3	2022	Polyoxometalates (POMs), a kind of inhibitors to beta-amyloid peptide (Abeta) aggregation, are used as an example to exhibit the chemical PTM methods.	polyoxometalate I	0-16	amyloid beta precursor protein	Homo sapiens	71-76